Beneficient (NASDAQ:BENF – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($1.49) earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by ($1.64), Zacks reports.
Beneficient Stock Performance
Shares of NASDAQ BENF traded down $0.00 during midday trading on Monday, reaching $0.62. The stock had a trading volume of 51,153 shares, compared to its average volume of 3,046,668. The company’s 50 day moving average price is $1.03 and its 200 day moving average price is $2.85. Beneficient has a twelve month low of $0.50 and a twelve month high of $9.96. The firm has a market cap of $9.66 million, a price-to-earnings ratio of -0.09 and a beta of 0.05.
Wall Street Analyst Weigh In
Several research analysts have commented on BENF shares. Wall Street Zen raised Beneficient to a “hold” rating in a report on Saturday, October 24th. Weiss Ratings reissued a “sell (e+)” rating on shares of Beneficient in a research note on Monday, September 21st. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company presently has an average rating of “Sell”.
Get Our Latest Research Report on BENF
About Beneficient
Beneficient is a financial services company focused on providing liquidity and related services for investors in alternative assets, such as interests in private equity and other private funds. These investments can be difficult to sell, and the company’s services are intended to help holders access liquidity without waiting for a fund’s full life cycle to end. The company offers financing and transaction solutions for alternative-asset holders, alongside trust, custody, and administrative services.
Featured Stories
- Five stocks we like better than Beneficient
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
